human hepatitis b immunoglobulin

It is used for the prevention of hepatitis B in various cases: after accidental exposure in non-immunized persons, in patients undergoing hemodialysis, in newborns of mothers who are carriers of the virus, and in those who have not developed an immune response after vaccination. It is also indicated to prevent the recurrence of hepatitis B after a liver transplant.

Form: solution for injection

ATC: J06BB04

Manufacturer: INSTITUTO GRIFOLS S.A.

It is used to prevent hepatitis B recurrence after a virus-induced liver transplant and to provide rapid protection against hepatitis B in cases of accidental exposure, in patients undergoing hemodialysis, in infants of virus-carrying mothers, or in those who have not responded to vaccination.

Form: solution for injection

ATC: J06BB04

Manufacturer: KEDRION S.P.A.

It is used to prevent hepatitis B recurrence after a virus-induced liver transplant and to provide rapid protection against hepatitis B in case of accidental exposure (in unvaccinated individuals), in patients undergoing hemodialysis, in infants of virus-carrying mothers, or in those who have not responded to vaccination.

Form: solution for injection

ATC: J06BB04

Manufacturer: KEDRION S.P.A.

It is used to prevent hepatitis B recurrence after a liver transplant (in combination with antiviral therapy) and to provide rapid protection against the hepatitis B virus in case of accidental exposure, in patients undergoing hemodialysis, in infants of mothers who are carriers of the virus, or in those who have not responded to vaccination.

Form: solution for infusion, powder and solvent for preparation

ATC: J06BB04

Manufacturer: KEDRION S.P.A.

This medicinal product is used to provide immediate and long-term protection against hepatitis B. It is used to prevent infection in unvaccinated or incompletely protected individuals, to protect the transplanted liver in virus-positive patients, for infants of infected mothers, and for those who have not achieved adequate protection through vaccination.

Form: solution for infusion

ATC: J06BB04

Manufacturer: BIOTEST PHARMA GMBH

This medicinal product is used to prevent reinfection with hepatitis B virus (HBV) in patients who have undergone a liver transplant due to liver failure caused by hepatitis B. It is also used for hepatitis B immunoprophylaxis in cases of accidental exposure in non-immunized individuals, in patients undergoing hemodialysis, in newborns born to virus-carrying mothers, and in those who have not developed an immune response following vaccination.

Form: solution for infusion

ATC: J06BB04

Manufacturer: INSTITUTO GRIFOLS S.A.

It is used to prevent hepatitis B recurrence after a liver transplant and to provide rapid protection against the virus in case of accidental exposure (in unvaccinated individuals), in patients undergoing hemodialysis, in infants with a mother carrying the virus, or in those who have not responded to vaccination.

Form: solution for injection

ATC: J06BB04

Manufacturer: KEDRION S.P.A.

It is used to prevent hepatitis B recurrence after liver transplantation (in combination with antiviral therapy) and to provide rapid protection against the hepatitis B virus in cases of accidental exposure, in patients undergoing hemodialysis, in infants of carrier mothers, or in those who have not responded to vaccination.

Form: solution for infusion

ATC: J06BB04

Manufacturer: KEDRION S.P.A.

This medicine is used to prevent hepatitis B recurrence after a liver transplant (in combination with antiviral therapy) and to provide rapid protection against the hepatitis B virus in cases of accidental exposure, in patients undergoing hemodialysis, in infants of mothers who are carriers of the virus, or in those who have not responded to vaccination.

Form: solution for infusion, powder and solvent for preparation

ATC: J06BB04

Manufacturer: KEDRION S.P.A.

Zutectra is used to prevent hepatitis B reinfection in adults who have undergone a liver transplant (caused by liver failure due to hepatitis B) at least one week ago.

Form: solution for injection

ATC: J06BB04

Manufacturer: BIOTEST PHARMA GMBH